Elizabeth Czerepak's Net Worth

$0

Estimate Recalculated Mar 20, 2024 07:02PM EST

Who is Elizabeth Czerepak?

Elizabeth Czerepak does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ADVANCIS PHARMACEUTICAL CORP, Altimmune, Inc., Sorrento Therapeutics, Inc., SPECTRUM PHARMACEUTICALS INC, DELCATH SYSTEMS, INC., CANCER GENETICS, INC, Scilex Holding Co, and AFFYMAX INC.

SEC CIK

Elizabeth Czerepak's CIK is 0001263500

Past Insider Trading and Trends

2017 was Elizabeth Czerepak's most active year for acquiring shares with 4 total transactions. Elizabeth Czerepak's most active month to acquire stocks was the month of April. 2006 was Elizabeth Czerepak's most active year for disposing of shares, totalling 2 transactions. Elizabeth Czerepak's most active month to dispose stocks was the month of November. 2003 saw Elizabeth Czerepak paying a total of $0.00 for 2,442,210 shares, this is the most they've acquired in one year. In 2003 Elizabeth Czerepak cashed out on 4,444,444 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ADVANCIS PHARMACEUTICAL CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 25
Form 4
—
0
—
—
0
Jun 3
Form 4
∞
2.43M
—
—
2.43M
Oct 22
Form 4
—
0
—
—
0
Oct 16
Form 3
—
0
—
—
0
No matching records found

Altimmune, Inc. (ALT) Snapshot price: $10.3298

CFO and EVP Corp. Development

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Sep 22
Form 4
—
0
—
—
0
May 4
Form 3
—
0
—
—
0
Form 4
—
0
—
—
0
Oct 9
Form 3/A
—
0
—
—
0
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

Sorrento Therapeutics, Inc. (SRNEQ) Snapshot price: $0.0375

EVP & Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 18
Form 4
—
0
—
—
0
Nov 18
Form 3
—
0
—
—
0
No matching records found

SPECTRUM PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+300.00%
30K
—
—
40K
Jun 18
Form 4
∞
10K
—
—
10K
Jun 20
Form 3
—
0
—
—
0
No matching records found

DELCATH SYSTEMS, INC. (DCTH) Snapshot price: $4.68

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 12
Form 4
—
0
—
—
0
May 4
Form 4
—
0
—
—
0
Aug 5
Form 4
—
0
—
—
0
Nov 23
Form 3
—
0
—
—
0
No matching records found